최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기韓國資源植物學會誌 = Korean journal of plant resources, v.36 no.1, 2023년, pp.26 - 31
박소정 (국립안동대학교 생약자원학과) , 엄유리 (국립산림과학원 산림약용자원연구소) , 최민영 (국립안동대학교 생약자원학과) , 정진부 (국립안동대학교 생약자원학과)
In this study, we investigated in vitro inhibitory activity of wild-simulated ginseng (WSG) against non-alcoholic fatty liver disease using HepG-2 cells. T0901317 treatment increased the lipid accumulation in HepG-2 cells, but WSG treatment inhibited T0901317-mediated lipid accumulation. In addition...
Bacanli, M., S.A. Dilsiz, N. Basaran and A.A. Basaran. 2019.?Effects of phytochemicals against diabetes. Adv. Food Nutr.?Res. 89:209-238.
Bartlett, K. and S. Eaton. 2004. Mitochondrial beta-oxidation.?Eur. J. Biochem. 271:462-469.
Clark, J.M. 2006. The epidemiology of nonalcoholic fatty liver?disease in adults. J. Clin. Gastroenterol. 40(1):S5-S10.
Dujic, T., A. Causevic, T. Bego, M. Malenica, Z. Velija-Asimi,?E.R. Pearson and S. Semiz. 2016. Organic cation transporter?1 variants and gastrointestinal side effects of metformin in?patients with type 2 diabetes. Diabet. Med. 33:511-514.
Goyal, A., H. Arora and S. Arora. 2020. Prevalence of fatty?liver in metabolic syndrome. J. Family Med. Prim. Care 9:3246-3250.
Im, H.J., Y.C. Ahn, J.H. Wang, M.M. Lee and C.G. Son. 2021.?Systematic review on the prevalence of nonalcoholic fatty?liver disease in South Korea. Clin. Res. Hepatol. Gastroenterol.?45(4):101526.
Jung, J.I., J.M. Kim, H.S. Kim, H.S. Kim and E.J. Kim. 2019.?Immunostimulatory effect of wild-cultivated ginseng extract?via the increase in phygocytosis and cytokine secretions in?RAW 264.7 macrophages. J. Korean Soc. Food Sci. Nutr.?48:686-691.
Kang, K.M., J.Y. Lee, M.U. Kim and S.H. Lee. 2016. Effect of?quality characteristics and antioxidant activity of Korean?cultivated wild ginseng extract. J. Korean Soc. Food Sci.?Nutr. 45:1740-1746.
Kim, K., Y. Um, H.J. Eo, H.W. Park, K.S. Jeon and H.J. Kim. 2020. Study on the correlation between the ginsenoside contents and growth characteristics of wild-simulated ginseng?with different year-roots (Panax ginseng C.A. Meyer). Korean?J. Plant Res. 33(4):255-262.
Kim, M.W., S.R. Ko, K.J. Choi and S.C. Kim. 1987. Distribution?of saponin in various sections of Panax ginseng root and changes of its contents according to root age. Korean J. Ginseng Sci. 19:10-16.
Kim, S.J., S.S. Shin, B.I. Seo and S.Y. Jee. 2004. Effect of?mountain grown ginseng radix, mountain cultivated ginseng?radix, and cultivated ginseng radix on apoptosis of HL-60?cells. Korea J. Herb 19:41.
Koo, S.H. 2013. Nonalcoholic fatty liver disease: molecular?mechanisms for the hepatic steatosis. Clin. Mol. Hepatol.?19:210-215.
Kwon, S.J. and D.K. Chung. 2004. The immune-enhancing effect?of mountain gown ginseng, mountain cultivated ginseng,?and Panax ginseng. J. Oriental Neuropsychiatry 15:89-101.
Lee, G., G.H. Na, W.K. Kim, M.Y. Baik, H.J. Lee and J.K.?Hwang. 2017. Antiinflammatory effect of cultivated wild?Panax ginseng extracts at various ages in RAW 26 4.6?macrophages. Food Eng. Prog. 21:201-207.
Lee, G., G.S. Choi, J.Y. Lee, S.J. Yun, W.K. Kim, H.J. Lee, M.Y.?Baik and J.K. Hwang. 2017. Proximate analysis and antioxidant activity of cultivated wild Panax ginseng. Food Eng.?Prog. 21:208-214.
Lee, S.M., S.Y. Park, G.S. Jang and S.Y. Ly. 2008. The protective effects of ethanol extract of wild-simulated ginseng on?carbon tetrachloride induced acute hepatic injury in mouse.?Korean J. Nutr. 41(8):701-710.
Liu, Y., D.K. Qiu and X. Ma. 2012. Liver X receptors bridge?hepatic lipid metabolism and inflammation. J. Dig. Dis. 13:69-74.
Park, J.D. 1996. Recent studies on the chemical constituents of?Korean ginseng (Panax ginseng C.A Meyer). Korean J. Ginseng Sci. 20:389-415.
Pydyn, N., K. Miekus, J. Jura and J. Kotlinowski. 2020. New?therapeutic strategies in nonalcoholic fatty liver disease: a?focus on promising drugs for nonalcoholic steatohepatitis.?Pharmacol. Rep. 72:1-12.
Steffensen, K.R. and J.A. Gustafsson. 2004. Putative metabolic?effects of the liver X receptor (LXR). Diabetes 53(1):S36-S42.
Takahashi, Y., K. Sugimoto, H. Inui and T. Fukusato. 2015.?Current pharmacological therapies for nonalcoholic fatty?liver disease/nonalcoholic steatohepatitis. World J. Gastroenterol. 21(13):3777-3785.
Younossi, Z., Q.M. Anstee, M. Marietti, T. Hardy, L. Henry, M.?Eslam, J. George and E. Bugianesi. 2018. Global burden of?NAFLD and NASH: trends, predictions, risk factors and?prevention. Nat. Rev. Gastroenterol. Hepatol. 15:11-20.
Younossi, Z.M. 2019. Non-alcoholic fatty liver disease - a?global public health perspective. J. Hepatol. 70:531-544.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.